SCHEMBL7676302

SCHEMBL7676302

C=CCn1cnnc1-c1c(Cl)c(Cl)cc2nc(OC)c(OC)nc12

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.33
PDE4B Q07343 1/20 0.31
PDE4D Q08499 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7824628 0.83 P2RX7 (0.33) P2RX7
SCHEMBL7673287 0.81 RAB9A (0.49) RAB9ASMN1; SMN2
SCHEMBL7676533 0.80 HRH4 (0.36) P2RX7SMN1; SMN2
SCHEMBL7681496 0.72 SMN1; SMN2 (0.43) SMN1; SMN2
SCHEMBL7678718 0.69 CYP1A2 (0.37) ALDH1A1SMN1; SMN2
SCHEMBL7680475 0.69 HRH4 (0.36)
SCHEMBL7682970 0.69 HRH4 (0.33)
SCHEMBL7818712 0.68 HRH4 (0.35)
SCHEMBL7676249 0.67 HRH4 (0.36)
SCHEMBL7473964 0.67 HRH4 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed